Dry eyes. Dry mouth. Fatigue. Joint pain. Vaginal dryness.
On their own, these symptoms may seem to point in different directions. A woman might mention one to her eye doctor, another to her dentist, another to her primary care physician or OB/GYN, at different times and for what may appear to be unrelated health concerns. But together, those symptoms may be telling a different story.
For women living with Sjögren’s disease (SjD), a systemic autoantibody-driven disease that can affect multiple parts of the body, connecting these symptoms can take years.1
New global survey research from Johnson & Johnson offers a closer look at that experience.
Across the findings a common thread emerged: women may be living with one systemic disease, but navigate a healthcare journey shaped by individual symptoms, and for many, that disconnect can still be felt even after a diagnosis is made.
Key findings
Understanding Sjögren’s disease
SjD is one of the most prevalent autoantibody-driven diseases, estimated to affect around four million people worldwide.2 It occurs when the immune system mistakenly attacks the body’s moisture-producing glands and other organs causing chronic dryness and inflammation.1
While SjD is commonly associated with dry eyes and dry mouth, it is a systemic disease that can affect multiple areas of the body, including the joints, lungs, kidneys and nervous system.3 This whole-body impact was reflected in the survey with women reporting effects beyond the mouth and eyes to areas including the joints, skin, muscles and reproductive system.
“Some primary care doctors and patients think of it as mainly dry eyes, dry mouth. There is not a lot of insight into the disease being a multi-systemic disease.”
The survey suggests this gap in understanding extends well beyond the doctor’s office.
The disease disproportionately affects women, who are nine times more likely than men to have SjD.4 But awareness among women surveyed in the general population was low: 69% had never heard of the disease and just 6% said they confidently knew what it was.
When it can take years to connect the symptoms
For many women surveyed, the path to an SjD diagnosis was not straightforward.
Ninety-five percent said they had been told their symptoms were unrelated to each other before they were diagnosed. Women recalled hearing explanations including stress, lack of sleep, anxiety or hormones. They also recalled being advised to use eye drops or drink more water.
This tendency to view symptoms in isolation extends beyond the patient experience. When presented with symptoms resembling SjD, women in the general population considered stress, hormones or dehydration as possible causes, with just 24% considering an underlying chronic disease.
As one woman explained:
For some women, finding an answer meant moving between multiple healthcare professionals, and for many, the process took years: 79% said it took between three and nine years from first experiencing symptoms to receiving an SjD diagnosis.
During that time, their symptoms did not necessarily stand still. More than half said worsening symptoms ultimately led to their diagnosis. Others reported that symptoms became more severe or began affecting new areas of their body before they were diagnosed.
A whole-body disease can create a whole-life burden
Receiving a diagnosis can finally give a name to what someone has been experiencing. But knowing the name of the disease does not necessarily make its impact disappear.
Two-thirds (66%) of women surveyed said their symptoms significantly affect their daily lives every day or most days.
Those effects reach far beyond physical symptoms alone, touching women’s sleep and daily function, emotional wellbeing and relationships, as well as their work and social lives. For some, SjD has influenced much bigger decisions: more than one third said the disease has caused them to delay major life decisions.
One woman described the personal cost:
There can be financial consequences too. Nearly three-quarters reported financial strain associated with managing SjD, including costs associated with testing, consultations, travel, medications and products used to manage symptoms over time.
One rheumatologist put it simply:
Being treated doesn’t always mean feeling in control
Diagnosis can be an important turning point. But the research suggests that for many women, identifying the disease and beginning treatment does not necessarily bring a sense of control.
Nearly all the women surveyed said they had been prescribed symptom-directed treatments such as artificial tears, saliva substitutes or vaginal moisturizers.
Yet 68% said they feel they are managing individual symptoms as they arise rather than controlling their disease, and more than half said their symptoms had stayed the same or worsened.
One woman surveyed described the uncertainty:
Healthcare professionals also described the challenges of managing different manifestations of SjD and how care can focus on the specific symptoms causing the greatest problems for an individual patient.
These patterns reveal an important distinction: being treated and feeling that SjD is under control are not necessarily the same thing.
What comes next?
Alongside the day-to-day burden of SjD, many women surveyed are thinking about what the disease could mean for their future health.
More than three-quarters said they fear the long-term impact of the disease despite being on treatment. Many are also concerned about progression beyond parts of the body already affected, with 77% worried SjD will impact other areas of the body and a similar proportion worried about potential severe or life-threatening complications.
For one woman, that uncertainty comes from what she cannot see:
Another said:
Those concerns are accompanied by a desire for more information. Three-quarters of women surveyed said they would like to be better informed by their doctor about new medical advancements.
That appetite for greater understanding extends to healthcare professionals too. Those interviewed for the research described a need for continued progress in SjD research and for options that go beyond addressing individual symptoms.
Seeing the whole disease
The experiences captured span different stages of the SjD journey, but they point to the same fundamental idea.
Before diagnosis, women can spend years trying to understand how seemingly unrelated symptoms fit together. After diagnosis, many continue to live with effects that reach across their health, work, relationships, social lives and plans for the future. And despite widespread use of symptom-directed treatments, many said they still feel they are managing symptoms rather than controlling their disease.
“Sjögren’s disease can show up in many different ways, and symptoms like dryness, fatigue and joint pain may initially seem unrelated. What stands out in these findings is that this disconnect can appear at different points in the patient journey, reinforcing the importance of connecting the dots and recognizing Sjögren’s as a systemic disease, rather than looking only at the individual symptoms people experience day to day.
Importantly, treating a symptom such as dry eye does not necessarily mean the underlying systemic disease is controlled or that progressive damage to the eyes or elsewhere in the body is being prevented. That distinction matters. It underscores why we need to keep advancing our understanding of Sjögren’s and continue research into its underlying biology as we work toward a future where patients can expect more from their care.”
The women surveyed are clear about what matters to them: understanding what is happening in their bodies, having greater confidence about what the future may hold and hearing about advances that could change the way SjD is understood and managed.
Their experiences underscore the importance of looking beyond individual symptoms to see the whole disease.
Explore our survey findings to see the bigger picture of life with SjD.
About the research
Johnson & Johnson commissioned a survey of 1,000 women across the United States, Germany and Brazil. Research was conducted from June 9–23, 2026. The 20-minute online survey included 300 women diagnosed with Sjögren’s disease and 700 women from the general population. All participants were age 18 or older; women with Sjögren’s were living with mild to severe disease, while general population participants were recruited to reflect the female population in each market. Five in-depth interviews with U.S. healthcare professionals were also conducted to provide additional context to the survey findings. The study was a small, cross-sectional survey based on participants’ self-reported Sjögren’s diagnosis and/or health status. The survey was not treatment-comparative and included participants’ self-reported experiences and perceptions without clinical assessment. This may limit generalizability.
References:
- Global Autoimmune Institute. Sjögren disease. Available at: https://www.autoimmuneinstitute.org/autoimmune-resources/autoimmune-diseases-list/sjogren-syndrome/.
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
Last accessed: October 2026.You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
- Beydon, M., et al. Epidemiology of Sjögren syndrome. Nat Rev Rheumatol. 2024 Mar;20(3):158-169. doi: 10.1038/s41584-023-01057-6.
- Carsons SE, Patel BC. Sjogren Syndrome. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431049/
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
- National Institute of Health. Sjogren’s Disease. https://www.nidcr.nih.gov/health-info/sjogrens-disease.
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
Last accessed: October 2026.You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.